Compare Trump Media and Technology Group Corp (DJT) vs Novartis AG (NVS) Price & Performance

Trump Media and Technology Group CorpTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Trump Media and Technology Group Corp vs Novartis AG — how do they compare? Trump Media and Technology Group Corp trades at $8.97 (market cap $2.48B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 119.1× Trump Media and Technology Group Corp's market cap, and Novartis AG pays a 3.07% dividend while Trump Media and Technology Group Corp pays none. Which is the better fit depends on your goals.

	DJT	NVS
Market Cap	$2.48B	$295.37B
Sector	Media	Health
52-Week High	$18.50	$168.62
52-Week Low	$7.06	$119.31
Enterprise Value	$2.54B	$336.69B
Dividend Yield	—	3.07%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DJT

Trump Media reports Q2 sales up 89% but still unprofitable with rising losses and stagnant operations.Seeking Alpha · 4 hours agoBearish Trump Media & Technology Group reports $238M loss on under $2M revenue in Q2, hit by digital asset declinesCNBC · 1 day agoBearish Trump Media shares drop 8% ahead of Q2 earnings, reflecting weak ad revenue and investor caution.Forbes · 1 day agoBearish View details →

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

About Trump Media and Technology Group Corp

Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.